BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18483302)

  • 21. Combinatorial Use of Chitosan Nanoparticles, Reversine, and Ionising Radiation on Breast Cancer Cells Associated with Mitosis Deregulation.
    Piña Olmos S; Díaz Torres R; Elbakrawy E; Hughes L; Mckenna J; Hill MA; Kadhim M; Ramírez Noguera P; Bolanos-Garcia VM
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31083605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models.
    Hardwicke MA; Oleykowski CA; Plant R; Wang J; Liao Q; Moss K; Newlander K; Adams JL; Dhanak D; Yang J; Lai Z; Sutton D; Patrick D
    Mol Cancer Ther; 2009 Jul; 8(7):1808-17. PubMed ID: 19567821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A thienopyrimidine derivative induces growth inhibition and apoptosis in human cancer cell lines via inhibiting Aurora B kinase activity.
    Li J; Hu H; Lang Q; Zhang H; Huang Q; Wu Y; Yu L
    Eur J Med Chem; 2013 Jul; 65():151-7. PubMed ID: 23707920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.
    Hook KE; Garza SJ; Lira ME; Ching KA; Lee NV; Cao J; Yuan J; Ye J; Ozeck M; Shi ST; Zheng X; Rejto PA; Kan JL; Christensen JG; Pavlicek A
    Mol Cancer Ther; 2012 Mar; 11(3):710-9. PubMed ID: 22222631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283.
    Curry J; Angove H; Fazal L; Lyons J; Reule M; Thompson N; Wallis N
    Cell Cycle; 2009 Jun; 8(12):1921-9. PubMed ID: 19440047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzo[e]pyridoindoles, novel inhibitors of the aurora kinases.
    Hoang TM; Favier B; Valette A; Barette C; Nguyen CH; Lafanechère L; Grierson DS; Dimitrov S; Molla A
    Cell Cycle; 2009 Mar; 8(5):765-72. PubMed ID: 19221479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening.
    Fu DH; Jiang W; Zheng JT; Zhao GY; Li Y; Yi H; Li ZR; Jiang JD; Yang KQ; Wang Y; Si SY
    Mol Cancer Ther; 2008 Aug; 7(8):2386-93. PubMed ID: 18723485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism.
    Liu LL; Long ZJ; Wang LX; Zheng FM; Fang ZG; Yan M; Xu DF; Chen JJ; Wang SW; Lin DJ; Liu Q
    Mol Cancer Res; 2013 Nov; 11(11):1326-36. PubMed ID: 24008673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.
    Yang J; Ikezoe T; Nishioka C; Tasaka T; Taniguchi A; Kuwayama Y; Komatsu N; Bandobashi K; Togitani K; Koeffler HP; Taguchi H; Yokoyama A
    Blood; 2007 Sep; 110(6):2034-40. PubMed ID: 17495131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel.
    Shimomura T; Hasako S; Nakatsuru Y; Mita T; Ichikawa K; Kodera T; Sakai T; Nambu T; Miyamoto M; Takahashi I; Miki S; Kawanishi N; Ohkubo M; Kotani H; Iwasawa Y
    Mol Cancer Ther; 2010 Jan; 9(1):157-66. PubMed ID: 20053775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversine induces multipotency of lineage-committed cells through epigenetic silencing of miR-133a.
    Kim M; Yi SA; Lee H; Bang SY; Park EK; Lee MG; Nam KH; Yoo JH; Lee DH; Ryu HW; Kwon SH; Han JW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):255-62. PubMed ID: 24513286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition.
    Vidarsdottir L; Steingrimsdottir G; Bodvarsdottir SK; Ogmundsdottir HM; Eyfjord JE
    Invest New Drugs; 2012 Apr; 30(2):425-34. PubMed ID: 20960027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.
    Lee YR; Wu WC; Ji WT; Chen JY; Cheng YP; Chiang MK; Chen HR
    J Biomed Sci; 2012 Jan; 19(1):9. PubMed ID: 22283874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells.
    Kuo CH; Lu YC; Tseng YS; Shi CS; Chen SH; Chen PT; Wu FL; Chang YP; Lee YR
    Breast Cancer; 2014 May; 21(3):358-69. PubMed ID: 22926505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo.
    Oke A; Pearce D; Wilkinson RW; Crafter C; Odedra R; Cavenagh J; Fitzgibbon J; Lister AT; Joel S; Bonnet D
    Cancer Res; 2009 May; 69(10):4150-8. PubMed ID: 19366807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.
    Huang XF; Luo SK; Xu J; Li J; Xu DR; Wang LH; Yan M; Wang XR; Wan XB; Zheng FM; Zeng YX; Liu Q
    Blood; 2008 Mar; 111(5):2854-65. PubMed ID: 18160664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aurora-B kinase inhibitors for cancer chemotherapy.
    Yeung SC; Gully C; Lee MH
    Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780.
    Nair JS; Ho AL; Tse AN; Coward J; Cheema H; Ambrosini G; Keen N; Schwartz GK
    Mol Biol Cell; 2009 Apr; 20(8):2218-28. PubMed ID: 19225156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias.
    Moore AS; Blagg J; Linardopoulos S; Pearson AD
    Leukemia; 2010 Apr; 24(4):671-8. PubMed ID: 20147976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors.
    Lee E; An Y; Kwon J; Kim KI; Jeon R
    Bioorg Med Chem; 2017 Jul; 25(14):3614-3622. PubMed ID: 28529042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.